Harrow: Drug Development and Supply Chains – Six Business Analyses

Which ophthalmic portfolio areas may deserve investment, selective support, harvesting or closer review as market conditions change?

A Harrow BCG Matrix helps organize portfolio discussions around market growth and relative market share, rather than treating every medicine or development opportunity as equally strategic. For an ophthalmic pharmaceutical business with approved-product pathways, clinical work and manufacturing partners, the question is how resource requirements differ across mature products, developing opportunities and smaller positions. The framework uses Stars, Cash Cows, Question Marks and Dogs as analytical categories; it does not assume that any Harrow product already belongs in a particular quadrant. It is useful for comparing where commercial attention, supply planning and capital allocation may have different roles.

• Portfolio signals. Compare growth conditions and relative-share evidence for product groups without inventing market-share conclusions.
• Resource trade-offs. Consider whether clinical, regulatory, manufacturing and commercial resources are aligned with each portfolio area's strategic role.
• Working map. Use the Excel framework to organize inputs, then use the Word analysis to interpret the assumptions and portfolio-priority questions behind them.

What industry pressures could influence the attractiveness and defensibility of ophthalmic pharmaceutical opportunities?

Harrow Porter's Five Forces examines rivalry, supplier power, buyer power, threat of new entrants and threat of substitutes around the relevant ophthalmic pharmaceutical markets. Competition can involve approved alternatives, product differentiation and access to prescribers or care channels. Supplier power is relevant where manufacturing capacity, quality standards, active ingredients or specialized services affect continuity. Buyer power may depend on the influence of healthcare purchasing channels and reimbursement-linked economics. New entrants must overcome regulatory, development and commercial barriers, while substitutes include alternative ways of addressing an eye-care need rather than only direct pharmaceutical competitors. The lens helps frame pressure points without assigning unsupported force scores.

• Competitive structure. Separate direct rivalry from substitute solutions and from the barriers that may shape entry into ophthalmic categories.
• Leverage points. Assess where suppliers, purchasers, quality requirements or channel access could affect negotiating power and margins.
• Pressure testing. Use the Excel framework to compare each force consistently, with the Word analysis providing context for the questions behind each assessment.

Which external changes should be monitored when planning an ophthalmic pharmaceutical portfolio and operating model?

A Harrow PESTLE analysis, also commonly called PESTEL, considers Political, Economic, Social, Technological, Legal and Environmental influences. Political and legal questions can include healthcare policy, regulatory expectations, quality obligations and intellectual-property considerations, without asserting a particular new law. Economic analysis can explore healthcare affordability, purchasing conditions and input-cost pressure. Social factors may include eye-health awareness and patient or provider expectations. Technological change can affect development, manufacturing, diagnostics and data-enabled care, while environmental themes can influence sourcing, manufacturing practices and continuity planning. For Harrow, this external scan is especially useful when considering how product approvals, contract manufacturing and supply systems may be exposed to change outside management's control.

• Policy horizon. Distinguish questions about regulation and reimbursement from verified policy changes before making strategic assumptions.
• Operating exposure. Consider how economic, technological and environmental shifts could affect manufacturing, quality systems and supply continuity.
• Monitoring agenda. Use the Excel framework to sort external signals by category and the Word analysis to develop their possible relevance to the business model.